Advances in treatment of MI reported at ACC show

Some patients with PAH need to travel long distances, which may impact their access to quality care providers.

In part 1 of our podcast series with American Associated Pharmacies (AAP), AAP President and CEO Jon Copeland dives into key pharmacy industry trends.

The atrial fibrillation drug, asundexian, may provide protection from thrombotic events without a corresponding increase in bleeding risk.

Our final episode in our ThoughtSpot 2020 podcast series features NPhA president Dr. Ryan Marable and immediate past president Dr. Lakesha Butler, who share insights on health disparities and the social determinants of health.

The specialty drug pipeline is projected to grow by 8% each year through 2025.

Findings reported in JAMA Network Open don’t find racial disparities among those who meet the treatment criteria. But Black individuals were less likely than Asian or White individuals to be among those meet the criteria.